Form D · Biotechnology

Orthera, Inc.

San Diego, CA · CIK 0001319625

Offering snapshot reported Jul 28, 2009 · SEC filing

Reported sold
$865K
Offering amount: $1.5M
Investors reported
15
Form D · investor count
Minimum accepted
$25K
Reported outside-investor minimum
First sale
Nov 18, 2008
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jul 28, 2009Initial$865,000No comparison15SEC filing
Jul 28, 2009Initial$690,000No comparison11SEC filing
Jan 26, 2009PaperNot reportedNo comparisonNot reportedSEC filing
Sep 23, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Feb 28, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Feb 28, 2005PaperNot reportedNo comparisonNot reportedSEC filing
Feb 28, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
06
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-74540

Source: Form D, filed Jul 28, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Geoffrey B. Boyes Director, Executive
Ronald A. Lavigna Director
Thomas Pichler Director, Executive
Daljeet Singh Director
Amar Singh Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
6190 Fairmount Avenue Suite E
San Diego, CA, 92120